E. Ohman J:or Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$24M |
| 2 |
Morgan Stanley
MS
|
+$23.8M |
| 3 |
HOLX
Hologic
HOLX
|
+$22.7M |
| 4 |
SIVB
SVB Financial Group
SIVB
|
+$21.7M |
| 5 |
MASI
Masimo
MASI
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$26.1M |
| 2 |
Centene
CNC
|
+$22.5M |
| 3 |
Goldman Sachs
GS
|
+$19.4M |
| 4 |
Encompass Health
EHC
|
+$18.5M |
| 5 |
Citigroup
C
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.26% |
| 2 | Healthcare | 15.69% |
| 3 | Financials | 14.89% |
| 4 | Consumer Discretionary | 14.21% |
| 5 | Communication Services | 12% |
Similar funds
E. Ohman J:or Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, E. Ohman J:or Asset Management held 443 positions worth $2.02B, up 16% from $1.74B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
E. Ohman J:or Asset Management deployed $128M of net new capital in Q3 2020, opening 14 new positions and adding to 200 existing holdings. Its largest new stake was Masimo: 93,350 shares worth $22M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $26.1M trimmed.
- E. Ohman J:or Asset Management's largest Q3 2020 buy was Masimo: 93,350 shares worth $22M.
- E. Ohman J:or Asset Management added most to Ciena in Q3 2020, an estimated $24M increase.
- E. Ohman J:or Asset Management's biggest Q3 2020 reduction was BioMarin Pharmaceuticals, cutting an estimated $26.1M.
- E. Ohman J:or Asset Management fully exited Goldman Sachs in Q3 2020, selling an estimated $19.4M.
- E. Ohman J:or Asset Management's ten largest holdings make up 36% of its $2.02B portfolio in Q3 2020.
- E. Ohman J:or Asset Management opened 14 new positions and closed 14 in Q3 2020.
- E. Ohman J:or Asset Management's portfolio value rose 16% quarter-over-quarter to $2.02B.
Based on E. Ohman J:or Asset Management's 13F filing for Q3 2020, filed 5 Apr 2024.